$2 million grant builds on research to develop sequence elements that improve DNA- and RNA-based medicine efficacy SAN DIEGO — Primrose Bio, Inc., a company with proprietary biologic manufacturing technologies, today announced a $2 million, 24-month Direct-to-Phase II Small Business Innovation Research award from the National Center for Advancing Translational Sciences (NCATS), part of the […]
San Francisco, California – Yavne, Israel – Genopore, the next-generation proteomics company developing the first semiconductor based optical nanopore technology platform with AI/ML analysis for direct single protein molecule identification and digital quantification, today announced the appointment of life science leader Rey Mali as its new Chief Executive Officer, with immediate effect. Rey Mali brings more […]
this appointment reflects the company’s continued growth through investment in leadership that pairs deep scientific credibility with real-world R&D experience SAN DIEGO — Rancho BioSciences today announced the appointment of John Reynders, PhD, MBA, to its Board of Directors. In his board role, Dr. Reynders will bring strategic depth to Rancho’s product direction and growth […]
Munich Regional Court finds Illumina infringes Element sequencing intellectual property, enjoins supply of Illumina systems and related consumables, and orders recall of affected devices SAN DIEGO, CA — Element Biosciences, Inc. today announced that the Regional Court of Munich I (Landgericht München I) has ruled that Illumina, Inc. and its German subsidiary, Illumina GmbH, infringe […]
ꟷ New, purpose-built facility at 225 Dyer Street in the 195 District reinforces Nabsys’ commitment to Providence’s growing life sciences and innovation district ꟷ Company will relocate its headquarters in July 2027, bringing manufacturing, technology development, R&D, and G&A together under one roof ꟷ Expansion supported by Rhode Island’s life sciences ecosystem and state economic development initiatives PROVIDENCE, […]
Research Opportunity to Use the 10x Genomics Xenium Platform for Spatially Resolved Transcriptomic Profiling and Cell Identity Analysis Piscataway, NJ – Sampled, an integrated analytical laboratory and biorepository, has partnered with 10x Genomics to offer a Spatial In Situ Gene Expression Services Grant, using the Xenium Prime 5K assay, for researchers across the United States. Spatial […]
Proprietary small-molecule formulation extends beyond conventional ROCK inhibitors to accelerate recovery and improve reproducibility in stem cell and organoid research. MONMOUTH JUNCTION, N.J. — TheWell Bioscience, a leader in xeno-free 3D cell culture technologies, today announced the launch of RocketCell™ Cell Viability Enhancer (1000X), a next-generation cell recovery reagent engineered to maximize cell survival, metabolic […]
SAN JOSE, Calif. — Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc. (“Takara Bio”), today announced that Carol Lou will retire as President and Chief Executive Officer of Takara Bio USA on July 10 after more than two decades with the company. Andrew Farmer, D.Phil., who has served as Chief Scientific […]
Uppsala, Sweden – Navinci Diagnostics AB (”Navinci”) today announces that the Company has initiated a pilot project together with Lumito AB (publ) (“Lumito”) to evaluate the possibilities of combining the companies’ respective technologies within advanced tissue analysis. The pilot project aims to combine Lumito’s high-sensitivity image analysis platform with Navinci’s in situ Proximity Ligation Technology (isPLA). By […]
Agreement with leading life sciences company Illumina strengthens Bifrost’s path to commercial deployment of next-generation optical pooled screening technology. BERKELEY, Calif. — Bifrost Biosystems today announced that it has secured a commercial supply agreement with Illumina enabling integration of Illumina’s industry-standard sequencing-by-synthesis (SBS) chemistry into its optical pooled screening (OPS) platform slated to be commercially available in early […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
